CD39 is mainly a (FOXP3 +) Treg marker [44]; in fact in melanoma and colon cancer models, ENTPD1-deficient mice displayed impaired Treg-suppressive functions [45]. This evidence concerns the gene FOXP3 and colonic neoplasm.